Dec. 5, 2024 — Improvements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than treatment advances, according to a modeling study.

This past year, the role of ctDNA testing has expanded to guide treatment decisions for providers and patients with cancer.

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...

Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.

More people without a history of smoking tobacco are being diagnosed with lung cancer. Oncologist Dr. Laura Alder with Duke Health said she often must remind people, “Anyone with lungs can get ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA (ctDNA), failed to accrue enough patients ...

Like most cancer types, the chance of developing lung cancer increases with age. In the United States, lung cancer is most often diagnosed in people 65 or older. But lung cancer can occur at any age, ...

This study is an example of the potential applications of ctDNA for the implementation of novel therapeutic strategies aimed at improving the care of cancer patients, and findings have led to the ...